Santiago Arroyo
Director/Board Member bij H. LUNDBECK A/S
Vermogen: 971 100 $ op 31-03-2024
Profiel
Momenteel bekleedt Santiago Arroyo de functie van Chief Medical Officer & Senior VP-Development bij Momenta Pharmaceuticals, Inc. Dr. Arroyo is tevens lid van de raad van bestuur van H. Lundbeck A. Dr. Arroyo bekleedde voorheen de functie van Chief Medical Officer-Biotherapeutics bij Pfizer Inc., Chief Medical Officer bij Boston Pharmaceuticals, Inc., Head-Neurosciences & Discovery Medicine bij Bristol Myers Squibb Co., Head-Global Clinical Development bij Eisai Co., Ltd., Associate Professor bij Hospital Clnic de Barcelona en Associate Professor bij The Medical College of Wisconsin, Inc. Santiago Arroyo behaalde een doctoraat aan de Universidad Autnoma de Madrid en een doctoraat aan de Universiteit van Barcelona.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 06-02-2024 | 39 000 ( 0.13% ) | 971 100 $ | 31-03-2024 |
Actieve functies van Santiago Arroyo
| Bedrijven | Functie | Begin |
|---|---|---|
| H. LUNDBECK A/S | Director/Board Member | 23-03-2021 |
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 31-03-2023 |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Director/Board Member | 02-05-2023 |
Eerdere bekende functies van Santiago Arroyo
| Bedrijven | Functie | Einde |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 13-11-2022 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01-05-2017 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01-10-2015 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01-01-2007 |
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Santiago Arroyo
| University of Barcelona | Doctorate Degree |
| Universidad Autónoma de Madrid | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 7 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Health Technology |
